The chromosomal locations of cellular sequences flanking integrated papillomavirws DNA in four cervical carcinoma cell lines and a primary cervical carcinoma have been determined. The two human papillomavirus (HPV) 16 flanking sequences derived from the tumor were localized to chromosome regions 20pter-*20ql3 and 3p25-+3qter, regions that also contain the protooncogenes c-src-l and c-raf-1, respectively. The HPV 16 integration site in the SiHa cervical carcinoma-derived cell line is in chromosome region 13ql4-+ 13q32. The HPV 18 integration site in SW756 cervical carcinoma cells is in chromosome 12 but is not closely linked to the Ki-ras2 gene. (8, 10) . We have therefore used the cloned cellular sequences that flank HPV DNA or the 3' terminal cellular sequences of cDNA clones to determine, by analysis of rodent-human hybrids retaining defined subsets of human chromosomes, the location of the integration sites on the human gene map.
The DNA of human papillomavirus (HPV) types 16 and 18 has been found closely associated with human genital cancers (1, 2) , supporting the idea that members of this virus group play a key role in the etiology of genital cancer (3) . HPV 16 and HPV 18 DNA sequences were also detected in cell lines derived from cervical cancer (2, (4) (5) (6) . The cell lines HeLa and SW756 contain HPV 18 DNA amplified about 10-to 50-fold together with the flanking cellular sequences, whereas SiHa and C4-I cells contain a single integrated copy of HPV 16 and 18 DNA, respectively (4) (5) (6) (7) (8) . In these cell lines and in most of the HPV-positive genital carcinomas, one of the opening points for viral integration is in the early region of the viral genome E1/E2 (4, 8) . As a consequence, only the E6, E7, and part of the El open reading frame and the adjacent cellular sequences can be transcribed from the early viral promoter. The analysis of cDNA clones derived from the HPV 18-containing cell lines HeLa, C4-I, and SW 756 has shown that most, if not all, HPV-positive mRNAs are virus-cell fusion transcripts. The host cell sequences that are spliced to the 5' HPV 18 exons are different for each cell line (9) . The mechanisms by which integration of HPV contributes to the malignant phenotype of the cell are not understood. Previous studies have shown that there are no specific sites for viral integration but the possibility of integration into a specific chromosomal domain could not be excluded (8, 10) . We have therefore used the cloned cellular sequences that flank HPV DNA or the 3' terminal cellular sequences of cDNA clones to determine, by analysis of rodent-human hybrids retaining defined subsets of human chromosomes, the location of the integration sites on the human gene map.
We have found integration sites on chromosomes 3 and 20 in a tumor that harbored multiple HPV 16 integration sites. Integration sites in four cervical carcinoma-derived cell lines were in three different chromosomes, 8, 12 , and 13.
MATERIALS AND METHODS
Integration Site Probes. 1.2A and 3.2A represent virus/cell junction fragments cloned from a HPV 16-positive cervical carcinoma that harbors multiple integration sites (7, 8) . For hybridization purposes, a 3.4-kilobase (kb) HindIII unique cellular fragment (3' of the viral integration site) was subcloned from 3 (17) and c-mos at 8q11 (18, 19) ; for chromosome 11, 3-globin at 11p15 (20) and Bcl-1 at 11q13 (21) ; for chromosome 13, three anonymous DNA clones, p7F12 at 13q13, p9D11 at 13q21, and p9A7 at 13q32 (22) ; tor chromosome 12, T4 at 12pl2-*pter (23) , , and the C8 homeo box containing gene at 12q12 (25) ; for chromosome 20, c-src-1 at 20q13 (26, 27) ; for chromosome 3, c-raf-1 at 3p25 (28) .
All probes were radiolabeled by nick-translation using a-P-labeled dNTPs to a specific activity of =1 x 10 cpm/0.1 ,g.
Cells. Isolation, propagation, and characterization of parental cells and somatic cell hybrids have been described (12-17, 23, 25 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (20pter--20ql3::14qll-44qter) and not the 14q-. For regional localization on chromosome 13, we used hybrid AC5 containing a 13q-(13pter-*13q14; 7q35--7qter) in the absence of 13ql4--13qter and normal 13 (P. Nowell, J. Finan, F. Haluska, and C.M.C., unpublished).
For regional localization on chromosome 8, parental cells HL60 and Colo 320 were used since they contain regions of DNA in the vicinity of the c-myc gene at 8q24 that are amplified >15-fold for myc and surrounding sequences (30) (31) (32) . Hybrid cells retaining translocated regions of chromosome 8 were also used. M442S (17) retains a 14q+ (14pter-+14q32::8q24--8qter) of a t(8;14) from an African Burkitt lymphoma, P3HR1. The chromosome 8 breakpoint is at least 35 kb 5' of the first c-myc exon (33); thus, the 5' sequences, c-myc, and the rest of chromosome 8 down to 8qter are translocated to the 14q+ chromosome. Additional hybrids of the JI series (34) retain t(2;8) chromosomes retaining defined regions of chromosome 8, and hybrid BC10 retains an 8q+ (8pter--8q24::14q11-14qter) from a T-cell leukemia (35) .
Southern Blot Analysis. Cellular DNAs were isolated as described (12) , digested with an excess of appropriate restriction enzymes, sized in 0.8% agarose gels, and transferred to nitrocellulose filters as described by Southern (36) . Hybridization took place in 50% formamide, 0.6 M NaCl/0.06 M sodium citrate, pH 7.0, 0.2 mg of sonicated salmon sperm DNA per ml, and lx Denhardt's solution (0.02% bovine serum albumin/0.02% Ficoll/0.02% polyvinylpyrrolidone) at 420C for 15 hr. After hybridization, filters were washed and exposed to Kodak XAR-5 film with intensifying screens.
RNA Transfer Blot Analysis. Cell lines originating from cervical cancer biopsies were obtained from the American Type Culture Collection or from M. Herlyn (Wistar Institute; SW756). Cytoplasmic RNA was prepared from HeLa, SW756, C4-I, CaSki, SiHa, and C33A cell lines as described elsewhere (37) , fractionated in 0.8% formaldehyde/agarose gels, transferred onto a nitrocellulose filter, and hybridized as described for Southern blot analysis. (26) , has been assigned to human chromosome region 20q13 (27) and, indeed, c-srcl cosegregates with the 1.2A probe in the hybrid panel (data not shown).
Using the same strategy, the sequences detected by probe 3.2A were localized to human chromosome 3 (see Fig. 1 , compare column for chromosome 3 with column on right for 3.2A). A Southern blot after hybridization with the 3.2A probe is shown in Fig. 3 ; lane 7 contains DNA from a hybrid, PB5, that does not retain the 3.2A integration site; this hybrid does, however, retain c-raft sequences (data not shown), which are at 3p25 (28) . Therefore, the 3.2A integration site is not closely linked to c-raft and is probably not located on region 3p25-3pter. Thus, the two integration sites from the tumor are localized at regions 20pter--20ql3, possibly near c-src-1, and 3p25-+3qter, probably not near c-raf7. HPV Genetics: Dfirst et al. this hybrid retains H4.1 sequences. Fig. 6A also illustrates the regional localization of H4.1 proximal to the c-myc gene at 8q24. Hybrid M442S in lane 6 contains DNA from a hybrid retaining a 14q+ chromosome (8q24-*8qter::14pter-14q32) from P3HR1 Burkitt lymphoma cells (17) . This 14q+ chromosome contains the region of chromosome 8 extending from the breakpoint at -30 kilobase pairs 5' of c-myc to the terminus ofthe long arm (8q24-*8qter) (17, 23) and is negative for the H4.1 probe (Fig. 6A, lane 6) . Conversely, hybrids retaining normal chromosome 8 (Fig. 6A, lanes 4, 7, 9, and 10) or the region 8pter--8q24 (Fig. 6A, lanes 8 and 11) extending from the tip of the short arm of chromosome 8 to a region 3' ofthe c-myc gene (34, 35) are positive for the H4.1 sequences. Thus, segregation of the H4.1 sequences in the hybrids retaining translocated regions of chromosome 8 allows assignment of this integration site on chromosome 8, 5 ' of the c-myc gene. On the same blot (Fig. 6A, lane 2) the human control is HL60 DNA, which has a region of -90 kb surrounding and including the c-myc gene, which is amplified 16-fold (30, 31) . Since we know that the amplification unit extends at least 50 kb on the 3' side of c-myc in HL60 (44) and the entire unit of amplification is -90 kb (45) (32) .
The HPV 18 integration site probe C33.1 from C4-I cells segregates in our hybrid panel 100% concordantly (Fig. 6B ) with the H4.1 probe (see Fig. 1 and compare Fig. 6 A and B) and is thus also on chromosome 8 proximal to c-myc (i.e., between 8pter--8q24, 5 ' of c-myc) but is not amplified in HL60 (Fig. 6B, lane 2 (Fig. 6C Right, lanes b and e, respectively) .
No HPV sequences in C33A cells (Fig. 6C, lane f) 
